Embigin is overexpressed in pancreatic ductal adenocarcinoma and regulates cell motility through epithelial to mesenchymal transition via the TGF-β pathway

Molecular Carcinogenesis
Dawoon E JungSi Young Song

Abstract

Embigin is a member of the immunoglobulin superfamily and encodes a transmembrane glycoprotein. There have been reports of Embigin involvement in neuromuscular junction formation and plasticity; however, the molecular functions of Embigin in other organs are unknown. Our aim was to investigate the possible role of Embigin in pancreatic cancer. In pancreatic ductal adenocarcinoma tissues, Embigin expression was higher than that in normal pancreatic tissues. Immunohistochemical analysis revealed expression of Embigin in pancreatic cancer cells, as well as expression of monocarboxylate transporter 2 (MCT2) in cancer tissues. To gain further insight, we transfected BxPC-3 and HPAC pancreatic cancer cells with siRNA or shRNA targeting Embigin and observed reductions in cell proliferation, migration, invasion, wound healing, and reduced levels of matrix metalloproteinases-2 and -9. Silencing of Embigin increased intracellular L-lactate concentration by 1.5-fold and decreased MCT2 levels at the plasma membrane. Furthermore, Embigin silencing led to a reduced expression of PI3K, GSK3-β, and Snail/Slug. Upon treating BxPC-3 cells with transforming growth factor-β (TGF-β), we observed elevated expression of Snail/Slug, Embigin, and Vimen...Continue Reading

References

Nov 1, 1990·Differentiation; Research in Biological Diversity·R P HuangT Muramatsu
Oct 24, 1998·The Journal of Biological Chemistry·R Y LinD W Golde
May 10, 2003·Pflügers Archiv : European journal of physiology·Andrew P Halestrap, David Meredith
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sanae NakajimaMasayuki Imamura
Nov 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ami A DeoraEnrique Rodriguez-Boulan
Apr 24, 2007·Seminars in Oncology·Michel DucreuxDavid Malka
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Birgit HotzHubert G Hotz
Oct 20, 2007·Experimental and Molecular Pathology·Kathryn T IaconoSandra J Saouaf
Jul 29, 2008·Connective Tissue Research·Eric HuetSuzanne Menashi
Aug 2, 2008·Neoplasia : an International Journal for Oncology Research·Ian F RobeyRobert J Gillies
Dec 17, 2008·Expert Review of Gastroenterology & Hepatology·Gary MiddletonJohn P Neoptolemos
Jan 23, 2009·Cancer Investigation·Heike VoigtRoland Houben
Jan 24, 2009·The Journal of Biological Chemistry·Enzo LainHans Rudolf Brenner
Mar 6, 2009·Nature Reviews. Cancer·Kornelia Polyak, Robert A Weinberg
Jul 9, 2009·Cancer Research·Thiruvengadam ArumugamWoonyoung Choi
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Jan 1, 2010·Critical Reviews in Eukaryotic Gene Expression·Michail R Ponisovskiy
Aug 7, 2012·Stem Cells·Eunyoung ChoiMark A Magnuson

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.